Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, more than 2 months after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles). The outcome of the shingles was not reported. The reporter considered the shingles to be possibly related to Shingrix. The company considered the shingles to be possibly related to Shingrix. Additional Information: GSK Receipt Date: 22-FEB-2026 This case was reported by a patient via interactive digital media. The patient had received a single injection approximately two and a half to three months earlier. The patient believed that this injection had precipitated the shingles and regarded it as the only likely cause. The batch number was not provided, and unable to contact the reporter.